[go: up one dir, main page]

WO2003011208A3 - Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea - Google Patents

Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea Download PDF

Info

Publication number
WO2003011208A3
WO2003011208A3 PCT/FR2002/002573 FR0202573W WO03011208A3 WO 2003011208 A3 WO2003011208 A3 WO 2003011208A3 FR 0202573 W FR0202573 W FR 0202573W WO 03011208 A3 WO03011208 A3 WO 03011208A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition based
lamellar phases
dhea compound
lamellar vesicles
dhea
Prior art date
Application number
PCT/FR2002/002573
Other languages
English (en)
Other versions
WO2003011208A2 (fr
Inventor
Jean-Thierry Simonnet
Original Assignee
Oreal
Jean-Thierry Simonnet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Jean-Thierry Simonnet filed Critical Oreal
Priority to JP2003516440A priority Critical patent/JP2004538295A/ja
Priority to AU2002334012A priority patent/AU2002334012A1/en
Priority to EP02791503A priority patent/EP1414412A2/fr
Priority to US10/484,000 priority patent/US20050013833A1/en
Publication of WO2003011208A2 publication Critical patent/WO2003011208A2/fr
Publication of WO2003011208A3 publication Critical patent/WO2003011208A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

La présente invention concerne une composition comprenant : .une dispersion, dans une phase aqueuse externe, de vésicules formées par des phases lamellaires lipidiques comprenant au moins un lipide amphiphile et encapsulant une phase hydrophile interne, lesdites phases lamellaires ne comprenant pas de dérivés succiniques et/ou hémi-succiniques, et .au moins un composé à base de DHEA inclus dans lesdites phases lamellaires. L'incorporation du composé a base de DHEA dans les phases lamellaires des vésicules permet d'éviter sa recristallisation dans la phase aqueuse externe et d'améliorer sa biodisponibilité.
PCT/FR2002/002573 2001-07-27 2002-07-18 Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea WO2003011208A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2003516440A JP2004538295A (ja) 2001-07-27 2002-07-18 少なくとも１種のｄｈｅａ化合物を導入した脂質ラメラ小胞に基づく組成物
AU2002334012A AU2002334012A1 (en) 2001-07-27 2002-07-18 Composition based on lipid lamellar vesicles incorporating at least a dhea compound
EP02791503A EP1414412A2 (fr) 2001-07-27 2002-07-18 Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea
US10/484,000 US20050013833A1 (en) 2001-07-27 2002-07-18 Composition based on lipid lamellar vesicles incorporating at least a dhea compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/10111 2001-07-27
FR0110111A FR2827766A1 (fr) 2001-07-27 2001-07-27 Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea

Publications (2)

Publication Number Publication Date
WO2003011208A2 WO2003011208A2 (fr) 2003-02-13
WO2003011208A3 true WO2003011208A3 (fr) 2003-11-27

Family

ID=8866019

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/002573 WO2003011208A2 (fr) 2001-07-27 2002-07-18 Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea

Country Status (6)

Country Link
US (1) US20050013833A1 (fr)
EP (1) EP1414412A2 (fr)
JP (1) JP2004538295A (fr)
AU (1) AU2002334012A1 (fr)
FR (1) FR2827766A1 (fr)
WO (1) WO2003011208A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830015A1 (fr) * 2001-09-27 2003-03-28 Berkem Sa Compositions a base de derives de steroides
RS52337B (en) * 2007-06-19 2012-12-31 Neubourg Skin Care Gmbh & Co. Kg DMS FOAM BASED CREAMS
US10045860B2 (en) 2008-12-19 2018-08-14 Amicus Design Group, Llc Interbody vertebral prosthetic device with self-deploying screws
PL2335675T3 (pl) 2009-12-10 2015-08-31 Neubourg Skin Care Gmbh & Co Kg Wolne od emulgatorów, stabilizowane polimerem formulacje pianki
US8685104B2 (en) 2012-03-19 2014-04-01 Amicus Design Group, Llc Interbody vertebral prosthetic and orthopedic fusion device with self-deploying anchors
US9566165B2 (en) 2012-03-19 2017-02-14 Amicus Design Group, Llc Interbody vertebral prosthetic and orthopedic fusion device with self-deploying anchors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0582503A1 (fr) * 1992-08-03 1994-02-09 L'oreal Composition formée d'une dispersion aqueuse de vésicules de lipides amphiphiles non-ioniques stabilisées
WO1997013500A2 (fr) * 1995-10-12 1997-04-17 Supergen, Inc. FORMULATION DE LIPOSOMES CONTENANT DES 5β STEROIDES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725369B1 (fr) * 1994-10-07 1997-01-03 Oreal Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
FR2803513B1 (fr) * 2000-01-12 2003-12-19 Oreal Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0582503A1 (fr) * 1992-08-03 1994-02-09 L'oreal Composition formée d'une dispersion aqueuse de vésicules de lipides amphiphiles non-ioniques stabilisées
WO1997013500A2 (fr) * 1995-10-12 1997-04-17 Supergen, Inc. FORMULATION DE LIPOSOMES CONTENANT DES 5β STEROIDES

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VINCENT M ET AL: "STEROID-LIPID INTERACTIONS IN SONICATED DIPALMITCYL PHOSPHATIDYL CHOLINE VESICLES: A STEADY-STATE AND TIME-RESOLVED FLUORESCENCE ANISOTROPY STUDY WITH ALL TRANS-1, 6-DIPHENYL-1,3,5-HEXATRIENE AS PROBE", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 113, no. 3, 29 June 1983 (1983-06-29), pages 799 - 810, XP000670310, ISSN: 0006-291X *

Also Published As

Publication number Publication date
AU2002334012A1 (en) 2003-02-17
WO2003011208A2 (fr) 2003-02-13
JP2004538295A (ja) 2004-12-24
FR2827766A1 (fr) 2003-01-31
US20050013833A1 (en) 2005-01-20
EP1414412A2 (fr) 2004-05-06

Similar Documents

Publication Publication Date Title
WO2004043363A8 (fr) Preparations liposomales d'agents pharmaceutiques stabilisees par des proteines
BR0214679A (pt) Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
WO2006117220A3 (fr) Methode d'administration d'une preparation liposomale cationique
WO1998038984A3 (fr) Preparations d'agents pharmaceutiques hydrophobes
EP1535613A3 (fr) Form polymorphe de atorvastatin calcium
WO2002051803A3 (fr) Nouveaux derives c-glycoside et utilisation
CA2370565A1 (fr) Compositions pharmaceutiques contenant de la vitamine d pour application cutanee
WO2000007979A3 (fr) Composes et compositions pour l'administration de principes actifs
WO2007059530A3 (fr) Compositions d’antitranspirants
WO2000003753A3 (fr) Systemes d'apport de medicaments par microdispersion
WO2009047006A3 (fr) Perfectionnements aux ou se rapportant aux liposomes amphotères comprenant des lipides neutres
AU4930299A (en) Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
WO2003051279A3 (fr) Compositions topiques et procedes d'application
WO2002043736A1 (fr) Aliments et boissons embellissants et preparations perorales embellissantes
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
WO2002076970A3 (fr) Derives succinate tocopherol et compositions
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
WO2003041682A3 (fr) Compositions a vecteurs lipidiques garantissant une meilleure retention medicamenteuse
WO2003011208A3 (fr) Composition a base de vesicules lamellaires lipidiques incorporant au moins un compose a base de dhea
IL161617A0 (en) Desmethyl and didesmethyl metabolites of citalopram, methods for the preparation thereof and pharmaceutical compositions containing the same
AUPR040600A0 (en) Polymeric formulation
WO2003026617A3 (fr) (ester)-lysolecithines dans des liposomen
AU4317500A (en) Antibiral compositions containing phorbol derivatives as the main active ingredient
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
TR200102778T2 (tr) Lipozom preparatları

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002791503

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003516440

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002791503

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10484000

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2002791503

Country of ref document: EP